Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Taylor

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Environmental Health Perspectives|May 6, 2006
Prenatal exposure to polychlorinated biphenyls and postnatal growth: a structural analysisMatthew R Lamb, Sylvia Taylor, Xinhua Liu, et al.
Expert Review of Vaccines|September 16, 2014
Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccineMaria-Genalin Angelo, Sylvia Taylor, Frank Struyf, et al.
Vaccine|December 5, 2016
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approachWirichada Pan-Ngum, Timothy Kinyanjui, Moses Kiti, et al.
Plos One|October 3, 2013
Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infantsAderonke Odutola, Martin Antonio, Olumuyiwa Owolabi, et al.
BMC Infectious Diseases|October 27, 2015
Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United KingdomDouglas M Fleming, Robert J Taylor, Roger L Lustig, et al.
BMJ Open|June 4, 2016
Modelling estimates of the burden of respiratory syncytial virus infection in children in the UKSylvia Taylor, Robert J Taylor, Roger L Lustig, et al.
Plos One|February 20, 2026
Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN studyAnshul Thakur, Bernardo Meza-Torres, Xuejuan Fan, et al.
Journal of Medical Internet Research|August 26, 2024
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and ValidationDebasish Kar, Kathryn S Taylor, Mark Joy, et al.
Expert Review of Vaccines|July 23, 2025
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysisAnke L Stuurman, Joshua Enxing, Aura V Gutiérrez, et al.
Infectious Diseases and Therapy|March 28, 2026
Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023Wilhelmine Meeraus, Lucy Carty, Sabada Dube, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Environmental Health Perspectives|May 6, 2006
Prenatal exposure to polychlorinated biphenyls and postnatal growth: a structural analysisMatthew R Lamb, Sylvia Taylor, Xinhua Liu, et al.
Expert Review of Vaccines|September 16, 2014
Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccineMaria-Genalin Angelo, Sylvia Taylor, Frank Struyf, et al.
Vaccine|December 5, 2016
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approachWirichada Pan-Ngum, Timothy Kinyanjui, Moses Kiti, et al.
Plos One|October 3, 2013
Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infantsAderonke Odutola, Martin Antonio, Olumuyiwa Owolabi, et al.
BMC Infectious Diseases|October 27, 2015
Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United KingdomDouglas M Fleming, Robert J Taylor, Roger L Lustig, et al.
BMJ Open|June 4, 2016
Modelling estimates of the burden of respiratory syncytial virus infection in children in the UKSylvia Taylor, Robert J Taylor, Roger L Lustig, et al.
Plos One|February 20, 2026
Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN studyAnshul Thakur, Bernardo Meza-Torres, Xuejuan Fan, et al.
Journal of Medical Internet Research|August 26, 2024
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and ValidationDebasish Kar, Kathryn S Taylor, Mark Joy, et al.
Expert Review of Vaccines|July 23, 2025
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysisAnke L Stuurman, Joshua Enxing, Aura V Gutiérrez, et al.
Infectious Diseases and Therapy|March 28, 2026
Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023Wilhelmine Meeraus, Lucy Carty, Sabada Dube, et al.
Pageof 5